Huilun Chu

1PUBLICATIONS
0CO-AUTHORS
Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 26, 2026
Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety Profile.

Huilun Chu, Guili Xu, Yunlong Liu

Pageof 1

Frequent Collaborators